Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management Dysgeusia (taste disturbance) is not listed in the UK Summary of Product Characteristics for Ozempic Potential contributing factors include gastrointestinal side effects, dehydration, concurrent medications, vitamin B12 deficiency, or oral health issues Management includes good oral hygiene, dietary modifications, staying hydrated, and reviewing concurrent medications with your healthcare provider Contact your GP if metallic taste persists beyond 23 weeks, affects nutritional intake, or accompanies other concerning symptoms Alternative diabetes medications include other GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy as recommended by NICE guidance Table of Contents What Causes Metallic Taste When Taking Ozempic
For patients with both obesity and type 2 diabetes, this makes the medication especially valuable in protecting long-term heart health
(NYSE: HIMS) today announced that a broad assortment of Novo Nordisks FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy pill, which is the only FDA-approved GLP-1 weight loss pill
and Vella, A
